Kimmelstiel CD, Maron BJ. Percutaneous septal ablation in hypertrophic cardiomyopathy. Circulation 2004; 109:452-456.
Kimmelstiel C. Septal Ablation for Hypertrophic Obstructive Cardiomyopathy. Chapter in The Cardiac Catheterization Handbook, Kern M, ed., Mosby, St. Louis, MO. 2004, Fourth Edition. pp 500-511.
Kimmelstiel C, Krishnamurthy B, Weintraub A,and Navin Kapur N. Alcohol septal ablation. Chinese J Cardiovasc Disease. 2009; 37(12):1074-7.
Kimmelstiel C. Reducing Arrhythmic Complications Following Alcohol Septal Ablation – The Utility of Lower Doses of Ethanol. Cath Cardiovasc Intervent. 2010; 75:551–552.
Kimmelstiel C. Percutaneous Relief of Valvular and Subvalvular Aortic Stenosis. Cath Cardiovasc Intervent 2010; 75:804–5.
Kimmelstiel C. Alcohol Septal Ablation in Young Children: Addressing Large Gradients in Little People. Cath Cardiovasc Intervent. 2010; 76:724-5.
Kimmelstiel C. Alcohol Septal Ablation via a Subendocardial Approach. Acute Effects in an Animal Model. Cath Cardiovasc Intervent. 2011; 78:324-5.
Nagy C, Kimmelstiel C. Use of intraprocedural CT imaging to guide alcohol septal ablation. Combining complementary imaging modalities. Catheter Cardiovasc Interv. 2012; 80:995-6.
Thomas SS, Kimmelstiel C. Alcohol Septal Ablation vs Surgical Myectomy for HCM- the Controversy Continues. Catheter Cardiovasc Interv. 2014; 83:278-9.
Bader Y, Kimmelstiel C. Ablation or surgery for medically refractory HCM. Updating an imperfect dataset. . Catheter Cardiovasc Interv. 2016; 88:116-7.
Kimmelstiel C. Alcohol Septal Ablation. Chapter in Cardiology Procedures, A Clinical Primer, Hendel RC, Kimmelstiel C eds., Springer-Verlag, London, UK 2016; pp 275-82.
Bader Y, Kimmelstiel C. Ablation or surgery for medically refractory HCM. Updating an imperfect dataset. . Catheter Cardiovasc Interv. 2016; 88:116-7.
Kimmelstiel C, Zisa D, Kuttab J, Wells S, Udelson J, Wessler B, Rastegar H, Kapur N, Weintraub A, Maron B, Maron M, Rowin E. Guideline-based referral in medically-refractory hypertrophic obstructive cardiomyopathy is associated with excellent clinical outcomes. Circ Cardiovasc Interv. 2019 Jul;12(7):e007673.
Rowin EJ, Kimmelstiel C. Combined alcohol septal ablation and transcatheter aortic valve replacement: Drunk and playing with fire. Catheter Cardiovasc Interv 2020; 95:838-9.
Kimmelstiel C, Rowin EJ. Fixed, high-volume alcohol dose for septal ablation: High risk with no benefit. Catheter Cardiovasc Interv. 2020;95:1219–1220.
Ommen S, Mital S, Burke MA, Day SA, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron M, Martinez MW, Miyake C, Schaff H, Semsarian C, Sorajja P. 2020 ACC/AHA Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2020;142:e533–e557.
Ommen S, Mital S, Burke MA, Day SA, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron M, Martinez MW, Miyake C, Schaff H, Semsarian C, Sorajja P. 2020 ACC/AHA Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2020; 76:159-240.
Ommen S, Mital S, Burke MA, Day SA, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron M, Martinez MW, Miyake C, Schaff H, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020 Dec 22;76(25):3022-3055. doi: 10.1016/j.jacc.2020.08.044. Epub 2020 Nov 20.PMID: 33229115.
Ommen S, Mital S, Burke MA, Day SA, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron M, Martinez MW, Miyake C, Schaff H, Semsarian C, Sorajja P.
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20.PMID: 33215938
Ommen S, Mital S, Burke MA, Day SA, Deswal A, Elliott P, Evanovich L, Hung J, Joglar J, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron M, Martinez MW, Miyake C, Schaff H, Semsarian C, Sorajja P. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2021 Apr 26:S0022-5223(21)00591-2. doi: 10.1016/j.jtcvs.2021.04.001.
Kimmelstiel C, Everett KD, Jain P, Miyashita S, Botto R, Resor C, Rowin E, Maron M, Kapur NK. Transcatheter mitral intervention relieves dynamic outflow obstruction and reduces cardiac workload in hypertrophic cardiomyopathy. Circ Heart Fail 2022; publication pending.
Carey Kimmelstiel, MD is the Director of the Interventional Cardiology Center at Tufts Medical Center and an Associate Professor at Tufts University School of Medicine. He specializes in interventional cardiology, was the first person to perform an alcohol septal ablation for HCM in New England and has been performing this procedure for more than 15 years. Dr. Kimmelstiel has been published extensively regarding the alcohol septal ablation technique and its outcomes in numerous top-tier cardiology journals. He was a member of the Writing Group for the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy. He was named a “Top Doctor” by Boston Magazine multiple times.
